Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System
Medical Care Technologies (OTC PINK:MDCE) has announced the development of an AI-driven Mole Tracking System for early skin cancer detection. The innovative system utilizes full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection to create comprehensive dermatological profiles.
The technology aims to reduce dependence on invasive biopsies and expensive clinic visits by providing a consumer-facing, mobile-accessible solution. The system will be integrated into MDCE's beta app, scheduled for launch in 2026. The company is targeting the global dermatology diagnostics market, which currently exceeds $15 billion annually.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato lo sviluppo di un Sistema di Tracciamento dei Nei basato su IA per la diagnosi precoce del cancro della pelle. Il sistema innovativo sfrutta l'indicizzazione delle lesioni su tutto il corpo, algoritmi di mappatura corporea 3D e il rilevamento temporale dei cambiamenti cutanei per creare profili dermatologici completi.
La tecnologia punta a ridurre la dipendenza da biopsie invasive e da costose visite cliniche offrendo una soluzione rivolta ai consumatori e accessibile da dispositivi mobili. Il sistema verr脿 integrato nell'app beta di MDCE, il cui lancio 猫 previsto per il 2026. L'azienda si rivolge al mercato globale della diagnostica dermatologica, che attualmente supera i $15 miliardi all'anno.
Medical Care Technologies (OTC PINK:MDCE) ha anunciado el desarrollo de un Sistema de Seguimiento de Lunares impulsado por IA para la detecci贸n temprana del c谩ncer de piel. El sistema innovador utiliza la indexaci贸n de lesiones en todo el cuerpo, algoritmos de mapeo corporal 3D y la detecci贸n temporal de cambios en la piel para crear perfiles dermatol贸gicos completos.
La tecnolog铆a busca reducir la dependencia de biopsias invasivas y de costosas visitas cl铆nicas ofreciendo una soluci贸n orientada al consumidor y accesible desde dispositivos m贸viles. El sistema se integrar谩 en la app beta de MDCE, cuyo lanzamiento est谩 previsto para 2026. La compa帽铆a apunta al mercado global de diagn贸stico dermatol贸gico, que actualmente supera los $15.000 millones anuales.
Medical Care Technologies (OTC PINK:MDCE)電� 臁瓣赴 頂茧秬鞎� 氚滉铂鞚� 鞙勴暅 AI 旮半皹 鞝�(氇皹) 於旍爜 鞁滌姢韰� 臧滊皽鞚� 氚滍憸頄堨姷雼堧嫟. 鞚� 順侅嫚鞝侅澑 鞁滌姢韰滌潃 鞝勳嫚 氤戨硛 鞚鸽嵄鞁�, 3D 鞁犾泊 毵ろ晳 鞎岅碃毽 氚� 鞁滉皠鞐� 霐半ジ 頂茧秬 氤�頇� 臧愳毳� 頇滌毄頃� 韽磩鞝侅澑 頂茧秬瓿� 頂勲韺岇澕鞚� 靸濎劚頃╇媹雼�.
鞚� 旮办垹鞚� 靻岆箘鞛愳毄 氇皵鞚� 鞝戧芳 臧�電ロ暅 靻旊（靺橃潉 鞝滉车頃溂搿滌崹 旃姷鞝� 靸濌瞼瓿� 瓿犼皜鞚� 歆勲 氚╇鞐� 雽�頃� 鞚橃〈霃勲ゼ 欷勳澊電� 瓴冹潉 氇╉憸搿� 頃╇媹雼�. 頃措嫻 鞁滌姢韰滌潃 2026雲勳棎 於滌嫓 鞓堨爼鞚� MDCE鞚� 氩犿儉 鞎膘棎 韱淀暕霅� 鞓堨爼鞛呺媹雼�. 須岇偓電� 順勳灛 鞐瓣皠 $150巩�鞚� 齑堦臣頃橂姅 旮�搿滊矊 頂茧秬瓿� 歆勲嫧 鞁滌灔鞚� 氇╉憸搿� 頃橁碃 鞛堨姷雼堧嫟.
Medical Care Technologies (OTC PINK:MDCE) a annonc茅 le d茅veloppement d'un Syst猫me de Suivi des Grains de Beaut茅 pilot茅 par IA pour la d茅tection pr茅coce du cancer de la peau. Le syst猫me innovant utilise l'indexation des l茅sions sur l'ensemble du corps, des algorithmes de cartographie corporelle 3D et la d茅tection des changements cutan茅s dans le temps pour cr茅er des profils dermatologiques complets.
La technologie vise 脿 r茅duire la d茅pendance aux biopsies invasives et aux visites cliniques co没teuses en proposant une solution destin茅e aux consommateurs et accessible depuis un mobile. Le syst猫me sera int茅gr茅 脿 l'application b锚ta de MDCE, dont le lancement est pr茅vu en 2026. La soci茅t茅 cible le march茅 mondial du diagnostic dermatologique, qui d茅passe actuellement les 15 milliards de dollars par an.
Medical Care Technologies (OTC PINK:MDCE) hat die Entwicklung eines KI-basierten Muttermal-Tracking-Systems zur fr眉hzeitigen Erkennung von Hautkrebs angek眉ndigt. Das innovative System nutzt die Indexierung von L盲sionen am ganzen K枚rper, 3D-K枚rperkartierungsalgorithmen und die zeitliche Erkennung von Hautver盲nderungen, um umfassende dermatologische Profile zu erstellen.
Die Technologie zielt darauf ab, die Abh盲ngigkeit von invasiven Biopsien und teuren Klinikbesuchen zu verringern, indem sie eine verbraucherorientierte, mobil zug盲ngliche L枚sung bietet. Das System wird in die Beta-App von MDCE integriert, deren Start f眉r 2026 geplant ist. Das Unternehmen richtet sich an den globalen Markt f眉r Dermatologie-Diagnostik, der derzeit mehr als $15 Milliarden j盲hrlich umfasst.
- Targeting $15 billion global dermatology diagnostics market with growth potential
- Innovative AI technology reduces need for invasive biopsies and costly clinic visits
- Mobile-accessible solution expands market reach to consumers
- Beta app launch not until 2026, indicating long time to market
- Faces regulatory approval hurdles and development timeline uncertainties
- Operating in highly competitive medical technology market
MESA, ARIZONA / / September 4, 2025 / Medical Care Technologies Inc. (OTC PINK: MDCE) is proud to announce the development of its AI-driven Mole Tracking System, a breakthrough dermatological monitoring tool for early skin cancer detection.
The system uses full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection to create longitudinal dermatological profiles for patients. This approach enables early identification of melanoma and other high-risk conditions, reducing reliance on invasive biopsies and costly clinic visits.
The global dermatology diagnostics market exceeds
"Skin cancer remains one of the most preventable yet deadly cancers when detected late," said CEO Marshall Perkins III. "Our technology empowers individuals and providers with AI-driven, real-time insights that can save lives."
The AI Mole Tracking platform is scheduled for inclusion in MDCE's beta app launch in 2026.
For more information visit:
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
[email protected]
Website:
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original on ACCESS Newswire
FAQ
What is MDCE's new AI Mole Tracking System?
When will MDCE launch its AI mole tracking app?
How big is the market opportunity for MDCE's skin cancer detection technology?
What advantages does MDCE's AI mole tracking system offer?
Who is the CEO of Medical Care Technologies (MDCE)?
